NIH Fiscal Policy for Grant Awards - FY 2017

Notice Number: NOT-OD-17-086

Key Dates
Release Date:  June 30, 2017

Related Announcements

Issued by
National Institutes of Health (NIH)


This Notice provides guidance about the NIH Fiscal Operations for FY 2017 and implements the Consolidated Appropriations Act, 2017 (Public Law 115-31), signed by President Trump on May 5, 2017.  With the passage of the Act, NIH received a $2 billion increase above FY2016, for a total of $34.30 billion in budget authority or equivalent (program level), including $352,000,000 from the 21st Century Cures Act.

The following NIH fiscal policies are instituted in FY 2017: 

FY 2017 Funding Levels: Non-competing continuation awards that have already been made in FY 2017 were generally funded at levels below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level) as described in NOT-OD-17-048.  In general, such reductions will be fully restored, and non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2017 will be made at the commitment level indicated on the Notice of Award.  Any exceptions will be posted at the site listed under "Additional Information" below.  Out-year commitments for continuation awards in FY 2018 and beyond will remain unchanged.  The NIH awarding Institutes/Centers (IC) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2017 funds.

Ruth L. Kirschstein National Research Service Awards (NRSA):  Consistent with the recommendations of the Advisory Committee to the Director regarding the Biomedical Research Workforce, the NIH will increase NRSA stipends by approximately 2 percent on average.  The full range of postdoctoral stipend adjustments for FY 2017 is described at NOT-OD-17-003. NIH will issue additional guidance on predoctoral stipends as appropriate.

New Investigators: NIH will continue to support new investigators on R01 equivalent awards at success rates comparable to that of established investigators submitting new (Type 1) R01 equivalent applications.  Achievement of comparable success rates should permit the NIH to support new investigators in accordance with the policies established in FY 2009 and subsequent years as described at and at

Salary Limits: Section 202 of the Consolidated Appropriations Act, 2017 prohibits payments for salaries under grants and other extramural mechanisms in excess of Executive Level II previously set at $185,100, and effective January 8, 2017, increased to $187,000.  See NOT-OD-17-049 for additional information. 

Other Legislative Mandates: Other statutory requirements are described in NOT-OD-17-075.

Additional Information:   Additional details on Fiscal Operations, including specific funding strategies for ICs will be posted at


Please direct all inquiries to:

Questions about specific awards may be directed to the Grants Management Specialist identified in the Notice of Award.